The Board Meeting held today i. e 13th May 2026 has approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026.
CHEMFAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Chemfab Alkalis reported a 10.4% decline in standalone revenue to Rs 28,857 Lakhs for FY2026 versus Rs 32,209 Lakhs in FY2025. Standalone net profit fell 50.7% to Rs 750.59 Lakhs (EPS Rs 5.22 vs Rs 10.65). On a consolidated basis, the company posted a net loss of Rs 342.65 Lakhs compared to a loss of Rs 694.03 Lakhs in the prior year, with consolidated revenue declining 7% to Rs 31,102 Lakhs. The consolidated loss was driven by the chemicals segment reporting a loss of Rs 1,710 Lakhs before tax, partially offset by the PVC-O Pipes segment profit of Rs 1,590 Lakhs. An exceptional gain of Rs 988.77 Lakhs was recorded in consolidated results. The board recommended a final dividend of Rs 1.25 per share (12.5%). Auditors Deloitte Haskins & Sells LLP issued an unmodified opinion on both standalone and consolidated results.
The stock may face pressure as both standalone profit and consolidated results deteriorated significantly, with the company slipping into consolidated net loss despite prior year losses. The revenue decline and segment underperformance in chemicals are key concerns for investors.